ACE Clinical Guidances (ACGs)

[also known as Appropriate Care Guides]

ACGs provide concise, evidence-based recommendations to inform specific areas of clinical practice and serve as a common starting point nationally for clinical decision-making. ACGs are underpinned by a wide array of considerations contextualised to Singapore, based on best available evidence at the time of development. Each ACG is developed in collaboration with a multidisciplinary group of local experts representing relevant specialties and practice settings. ACGs are not exhaustive of the subject matter and do not replace clinical judgement.

Published on 07 Oct 2022
Last Updated on 07 Oct 2022
A- A+

This ACE Clinical Guidance (ACG) highlights the importance of early identification of patients at increased risk of chronic kidney disease (CKD), providing evidence-based recommendations for timely detection, diagnosis, and staging of CKD.

Download the PDF below to access the ACG.

ACG recommendations
1.Identify patients at increased risk of CKD by assessing their risk factors and determine the need to evaluate for CKD.
2.Diagnose CKD if any of the following is present for at least three months:
  • GFR < 60 mL/min/1.73m2
  • UACR ≥ 3 mg/mmol (≥ 30 mg/g)
  • Other marker of kidney damage
3.Determine the stage of CKD based on GFR, UACR, and the cause(s) of CKD.
4.For patients diagnosed with CKD, discuss the diagnosis and management options with the patient.
5.For patients who do not have CKD but are at increased risk, monitor for CKD regularly.
6.Referral to a specialist could be made at any point.

CKD – early detection (October 2022) CKD – early detection References (Oct 2022)


Click here to give us feedback on this ACG.